Abbott starts trial on deep brain stimulation for depressive disorder
Abbott Laboratories has initiated a clinical trial to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a.
Drugs
Health
Pharma
Drugs
Health
Medical
Researchers identify 6 new biotypes of depression, paving way for better treatment options
HQ Team July 19, 2024:A new study from Stanford has identified six new subtypes of depression known as “biotypes” using brain imaging with.